VX-702

Background Information:

VX-702 is an orally bioavailable p38 MAP kinase inhibitor developed to treat inflammatory diseases.

Reference:

1. C. Ding, VX-702, a MAP kinase inhibitor for rheumatoid arthritis
and acute coronary syndrome, Current Opinion in Investigational Drugs,
2006 7:1020-1025.

APIM050260: VX-702

CAS No.: 479543-46-9.
Molecular Formula: C₁₉H₁₂F₄N₄O_2.
Molecular Weight: 404.32.
Purity: > 99% (HPLC).
QC: LC/MS, ¹HNMR, HPLC.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.